272 Capital’s MaxLinear MXL Stock Holding History

272 Capital’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$217K	–	28
2025 Q1	$217K	Buy	+20,000	New	+$335K	0.57%	24

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

272 Capital's MXL Position: Q2 2025 in Review

272 Capital sold out of MaxLinear (MXL) in Q2 2025, closing a stake of 20,000 shares — an estimated $217K sold.

272 Capital first reported a position in MXL in Q1 2025 and held it in 1 quarter. The position peaked at $217K in Q1 2025. 218 funds tracked by Wall St. Rank hold MXL as of Q2 2025.

272 Capital reported no remaining MaxLinear position as of Q2 2025 after selling out during the quarter.
272 Capital sold 20,000 MaxLinear shares in Q2 2025, an estimated $217K.
272 Capital first reported a position in MaxLinear in Q1 2025 and held it in 1 quarter.
272 Capital's MaxLinear position peaked at $217K in Q1 2025.
218 funds tracked by Wall St. Rank held MaxLinear as of Q2 2025.

Based on 272 Capital's 13F filing for Q2 2025, filed 14 Aug 2025.